Clinical Trials Logo

Filter by:
NCT ID: NCT04826549 Completed - Smoking, Cigarette Clinical Trials

A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application

COCO
Start date: March 22, 2021
Phase:
Study type: Observational

The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.

NCT ID: NCT04826328 Completed - Pain, Postoperative Clinical Trials

Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

Start date: March 15, 2021
Phase: Phase 1
Study type: Interventional

This two-part study will be conducted in male and female patients 18 to 65 years of age undergoing bunionectomy. Part I - three-step, single ascending dose study design in which two drug loads (low drug load of funapide and high drug load of funapide) and two volumes (high volume and low volume) of FX301 will be explored against placebo in four cohorts of 12 patients each (9 active:3 placebo) for the management of post-surgical pain in patients undergoing bunionectomy. Part II - expansion cohort to further assess safety, tolerability, systemic exposure, and efficacy of a selected drug load/volume of FX301. An additional 36 patients will be randomized in a 1:1 ratio to receive either FX301 or placebo as a single-injection analgesic nerve block adjacent to the sciatic nerve of the popliteal fossa.

NCT ID: NCT04826276 Completed - Behavior Clinical Trials

Effects of Smoking State on Decision Making

Effort
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Adult smokers will be tested using behavioral and neuroimaging measures after smoking as usual and after overnight abstinence.

NCT ID: NCT04826185 Completed - Clinical trials for Non-obstructive Hypertrophic Cardiomyopathy

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

IMPROVE-HCM
Start date: June 14, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, and potential efficacy of IMB-1018972 in patients with non-obstructive HCM.

NCT ID: NCT04826068 Completed - Clinical trials for Traumatic Brain Injury

Emotional Processing Intervention for Children With TBI

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Investigating an emotional processing program, that is modified for use with children, is effective for children with a traumatic brain injury (TBI).

NCT ID: NCT04825912 Completed - Clinical trials for Lung Cancer Stage IV

Resilience Measurement in Older Adults With Late-Stage Lung Cancer

SST Resilience
Start date: May 3, 2021
Phase: N/A
Study type: Interventional

The purpose of this study to test measures of physical and psychological resilience while using Self-System therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

NCT ID: NCT04825756 Completed - Anxiety Clinical Trials

Evaluating the Impact of Reining in Anxiety

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the impact of Reining in Anxiety for children with anxiety and their caregivers. A total of up to 80 child/caregiver dyads will be enrolled in the study, anticipating that 40 dyads will complete the 10 week intervention. The intervention will be delivered at Fieldstone Farm Therapeutic Riding Center, which is one of the largest therapeutic riding centers in the US.

NCT ID: NCT04825678 Completed - Migraine Clinical Trials

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Start date: June 11, 2021
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to evaluate the effect of erenumab on medication-specific treatment satisfaction.

NCT ID: NCT04825236 Completed - Cystic Fibrosis Clinical Trials

MyVoice:CF Decision Aid for Women With Cystic Fibrosis

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

This project is a single-center feasibility study of MyVoice:CF, a patient-facing, web-based decision aid. Aim 1) Assess the acceptability, feasibility, and usability of MyVoice:CF for women with CF and multidisciplinary adult CF providers. Aim 2) Assess the preliminary efficacy of MyVoice:CF related to patient-provider communication, shared decision-making, knowledge, and self-efficacy for women with CF related to reproductive health concerns.

NCT ID: NCT04825210 Completed - Prevention Clinical Trials

Integrated Behavioral Health Prevention in Pediatric Primary Care for Infants

Start date: April 13, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the acceptability and preliminary efficacy of a universal prevention program delivered by psychologists in conjunction with pediatric primary care well-child visits.